Source: Virtual Congress 2020 – Translational therapeutic advances
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Khan (Basel, Switzerland), J. Roux (Basel, Switzerland), S. Savic (Basel, Switzerland), L. Knudsen (Hannover, Germany), D. Jonigk (Hannover, Germany), M. Kuehnel (Hannover, Germany), A. Gazdhar (Bern, Switzerland), T. Geiser (Bern, Switzerland), M. Tamm (Basel, Switzerland), K. Hostettler (Basel, Switzerland). Fibrosis-specific stem-like cells in peripheral IPF lung: Characteristics and potential role. 3360

Member's Comments

No comment yet.

Related content which might interest you: The role of resident lung mesenchymal stromal cells in normal and aberrant lung development Source: Virtual Congress 2020 – Cellular involvement in lung injury Year: 2020 Identification and characterization of mesenchymal stem cells in the human lung Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 In search of ckit+ stem cells in lung tissue Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 IPF lung resident mesenchymal stem cells differentiate into epithelial cells displaying a disease-specific transcriptome Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2019 Identification of MSC-like cells in human lung parenchyma capable of differentiating into airway epithelial cells Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung Year: 2009 LSC - 2021 - Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021 PP238 – Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis Source: ERS Lung Science Conference 2021 Year: 2021 The expression and clinical significance of PD-L1+CD68+ macrophages in peripheral blood mononuclear cells of non-small cell lung cancer Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Oral presentation: Human lung parenchyma cells: a potential therapeutic cell source for lung disease Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Myeloid derived suppressor cell-like fibrocytes are increased and associated with preserved lung function in COPD Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Intersections of lung progenitor cells, lung disease and lung cancer Source: Eur Respir Rev, 26 (144) 170054; 10.1183/16000617.0054-2017 Year: 2017 Predicting prognosis of lung function decline in IPF using gene expression in peripheral blood mononuclear cells Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017 Reciprocal imbalance or coexistence? The distribution of Th17 and Treg cells in peripheral blood lymphocytes in patients with non-small-cell lung cancer and its significance Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Myeloid derived suppressor cells in the crosstalk between COPD and lung cancer Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD Year: 2011 Downregulation of mir-146a in peripheral blood mononuclear cells as a potential marker of NSCLC Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020